Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of PDE Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of PDE Inhibitorsmarket, defines the market attractiveness level of PDE Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of PDE Inhibitors industry, describes the types of PDE Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global PDE Inhibitors market and the development prospects and opportunities of PDE Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global PDE Inhibitors market in Chapter 13.
By Player:
Verona Pharma
Otsuka
Omeros
Pfizer
Boehringer Ingelheim
Hanmi Science Holding
Takeda Pharmaceuticals
Chiesi Farmaceutici
Anacor Pharmaceuticals
NuSirt Biopharma
By Type:
PDE5
PDE4
Viagra
Cialis
Levitra
Others
By End-User:
Genitourinary
Cardiovascular Diseases
Neurological Diseases
Dermatological Disorders
Respiratory Diseases
Other Indications
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 PDE Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 PDE Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 PDE Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 PDE Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise PDE Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global PDE Inhibitors Consumption (2017-2022)
-
7.2 United States PDE Inhibitors Consumption (2017-2022)
-
7.3 Europe PDE Inhibitors Consumption (2017-2022)
-
7.4 China PDE Inhibitors Consumption (2017-2022)
-
7.5 Japan PDE Inhibitors Consumption (2017-2022)
-
7.6 India PDE Inhibitors Consumption (2017-2022)
-
7.7 South Korea PDE Inhibitors Consumption (2017-2022)
8 Region and Country-wise PDE Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global PDE Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States PDE Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe PDE Inhibitors Consumption Forecast (2022-2028)
-
8.4 China PDE Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan PDE Inhibitors Consumption Forecast (2022-2028)
-
8.6 India PDE Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea PDE Inhibitors Consumption Forecast (2022-2028)
9 Global PDE Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global PDE Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PDE5 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PDE4 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Viagra Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cialis Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Levitra Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global PDE Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Genitourinary Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Dermatological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Respiratory Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Indications Consumption and Growth Rate (2017-2022)
10 Global PDE Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global PDE Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global PDE5 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global PDE4 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Viagra Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cialis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Levitra Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global PDE Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Genitourinary Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Dermatological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Respiratory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Indications Consumption Forecast and Growth Rate (2022-2028)
11 Global PDE Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global PDE Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global PDE Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 PDE Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global PDE Inhibitors Market Competitive Analysis
-
14.1 Verona Pharma
-
14.1.1 Verona Pharma Company Details
-
14.1.2 Verona Pharma PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Verona Pharma PDE Inhibitors Product and Service
-
14.2 Otsuka
-
14.2.1 Otsuka Company Details
-
14.2.2 Otsuka PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Otsuka PDE Inhibitors Product and Service
-
14.3 Omeros
-
14.3.1 Omeros Company Details
-
14.3.2 Omeros PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Omeros PDE Inhibitors Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer PDE Inhibitors Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim PDE Inhibitors Product and Service
-
14.6 Hanmi Science Holding
-
14.6.1 Hanmi Science Holding Company Details
-
14.6.2 Hanmi Science Holding PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Hanmi Science Holding PDE Inhibitors Product and Service
-
14.7 Takeda Pharmaceuticals
-
14.7.1 Takeda Pharmaceuticals Company Details
-
14.7.2 Takeda Pharmaceuticals PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Takeda Pharmaceuticals PDE Inhibitors Product and Service
-
14.8 Chiesi Farmaceutici
-
14.8.1 Chiesi Farmaceutici Company Details
-
14.8.2 Chiesi Farmaceutici PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Chiesi Farmaceutici PDE Inhibitors Product and Service
-
14.9 Anacor Pharmaceuticals
-
14.9.1 Anacor Pharmaceuticals Company Details
-
14.9.2 Anacor Pharmaceuticals PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Anacor Pharmaceuticals PDE Inhibitors Product and Service
-
14.10 NuSirt Biopharma
-
14.10.1 NuSirt Biopharma Company Details
-
14.10.2 NuSirt Biopharma PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 NuSirt Biopharma PDE Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of PDE Inhibitors
-
Figure PDE Inhibitors Picture
-
Table Global PDE Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PDE Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PDE Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global PDE Inhibitors Consumption by Country (2017-2022)
-
Figure United States PDE Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe PDE Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China PDE Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan PDE Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India PDE Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea PDE Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States PDE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe PDE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China PDE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan PDE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India PDE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea PDE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE5 Consumption and Growth Rate (2017-2022)
-
Figure Global PDE4 Consumption and Growth Rate (2017-2022)
-
Figure Global Viagra Consumption and Growth Rate (2017-2022)
-
Figure Global Cialis Consumption and Growth Rate (2017-2022)
-
Figure Global Levitra Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Genitourinary Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Indications Consumption and Growth Rate (2017-2022)
-
Figure Global PDE5 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Viagra Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cialis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Levitra Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genitourinary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Indications Consumption Forecast and Growth Rate (2022-2028)
-
Table Global PDE Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global PDE Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Verona Pharma (Foundation Year, Company Profile and etc.)
-
Table Verona Pharma PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Verona Pharma PDE Inhibitors Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka PDE Inhibitors Product and Service
-
Table Omeros (Foundation Year, Company Profile and etc.)
-
Table Omeros PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Omeros PDE Inhibitors Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer PDE Inhibitors Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim PDE Inhibitors Product and Service
-
Table Hanmi Science Holding (Foundation Year, Company Profile and etc.)
-
Table Hanmi Science Holding PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hanmi Science Holding PDE Inhibitors Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals PDE Inhibitors Product and Service
-
Table Chiesi Farmaceutici (Foundation Year, Company Profile and etc.)
-
Table Chiesi Farmaceutici PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiesi Farmaceutici PDE Inhibitors Product and Service
-
Table Anacor Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Anacor Pharmaceuticals PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anacor Pharmaceuticals PDE Inhibitors Product and Service
-
Table NuSirt Biopharma (Foundation Year, Company Profile and etc.)
-
Table NuSirt Biopharma PDE Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table NuSirt Biopharma PDE Inhibitors Product and Service
-
